Later studies have demonstrated that CD146 is highly expressed on a variety of carcinomas in addition to melanoma, and therefore CD146 has been suggested as a potential marker for tumor diagnosis, prognosis and treatment (Wang and Yan, 2013). This evidence concerns the gene MCAM and melanoma.